BMJ  2003;327 (11 October), doi:10.1136/bmj.327.7419.0-e

Trial results have dramatically reduced HRT use

The publication of the combined oestrogen-progestogen trial from the Women's Health Initiative, which generated extensive media coverage in 2002, has affected women's decisions to use hormone replacement therapy (HRT). In a cross sectional survey of women attending general practices in New Zealand, Lawton and colleagues (p 845) investigated the effect of the publication on the use of HRT in known users. Over half of those surveyed had stopped taking HRT, and stopping was significantly associated with increasing age, use of combined HRT, and use for more than five years. The authors say that women sought appropriate advice from health professionals and that stopping HRT was in line with recommendations in international guidelines.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users

Beverley Lawton, Sally Rose, Deborah McLeod, and Anthony Dowell
BMJ 2003 327: 845-846. [Full Text] [PDF]